Publikationen in Zusammenarbeit mit Forschern von VU University Medical Center (11)

2018

  1. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment

    Neuro-Oncology, Vol. 20, Núm. 11, pp. 1494-1504

2016

  1. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: Study ALL10 from the Dutch Childhood Oncology Group

    Journal of Clinical Oncology, Vol. 34, Núm. 22, pp. 2591-2601

2013

  1. Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood

    Leukemia

  2. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation

    Leukemia, Vol. 27, Núm. 7, pp. 1497-1503

2011

  1. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

    Leukemia, Vol. 25, Núm. 2, pp. 254-258

2010

  1. Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

    Leukemia, Vol. 24, Núm. 9, pp. 1599-1606

  2. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL

    Leukemia, Vol. 24, Núm. 7, pp. 1258-1264

1998

  1. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease

    Leukemia, Vol. 12, Núm. 7, pp. 1081-1088

1991

  1. Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade

    Leukemia, Vol. 5, Núm. 10, pp. 848-853

1990

  1. Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development

    Leukemia, Vol. 4, Núm. 5, pp. 383-389

1987

  1. Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis

    Journal of Neuroimmunology, Vol. 15, Núm. 3, pp. 243-249